Dragica Paunovic

Showing 1-6 of 6 articles

Five-year clinical outcome of the Nobori drug-eluting coronary stent system in the treatment of patients with coronary artery disease: final results of the NOBORI 1 trial

Chevalier B, Wijns W, Silber S, Garcia E, Serra A, Paunovic D, Serruys P

September 22, 2015 | 10.4244/EIJY14M12_13

Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study

Danzi G, Chevalier B, Urban P, Fath-Ordoubadi F, Carrié D, Wiemer M, Serra A, Wijns W, Kala P, Stabile A, Ruigomez J, Sagic D, Laanmets P, Strupp G, West N, Paunovic D

May 15, 2012 | 10.4244/EIJV8I1A17

MISAGO 1: first-in-man clinical trial with Misago™ nitinol stent

Schulte K, Müller-Hülsbeck S, Cao P, Becquemin J, Langhoff R, Charalambous N, Desgranges P, Kobeiter H, Midulla M, Borovicanin V, Paunovic D, Beregi J

January 15, 2010

First clinical comparison of Nobori –Biolimus A9 eluting stents with Cypher– Sirolimus eluting stents: NOBORI CORE nine months angiographic and one year clinical outcomes

Ostojic M, Sagic D, Beleslin B, Jung R, Perisic Z, Jagic N, Nedeljkovic M, Mangovski L, Milosavljevic B, Stojkovic S, Orlic D, Antonic Z, Miloradovic V, Topic D, Paunovic D

March 20, 2008

A novel ultra-thin bare metal stent (BMS): results from a worldwide registry

Blanchard D, Danzi G, Urban P, Moseri M, Juergens C, Guyon P, Nowak B, Tresukosol D, Suttorp MJ, Farshid A, Kornowski R, Garcia E, Yeend R, Nagai H, Paunovic D

August 20, 2007

Randomised comparison of Nobori™, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial

Chevalier B, Serruys P, Silber S, Garcia E, Suryapranata H, Hauptmann K-E, Wijns W, Schuler G, Fath-Ordoubadi F, Worthley S, Thuesen L, Meredith I, Bressers M, Nagai H, Paunovic D

February 20, 2007

1

Latest news

PCR e-Course; LM interventions; FFR and STEMI, the EAPCI and COVID-19; TMVR

Ahead of print: EAPCI Core Curriculum for PCI (2020)

IVUS guidance during left main PCI: not if, but when and how

Ahead of print: EAPCI Expert Consensus Document: Ischaemia with non-obstructive coronary arteries

V. Kunadian et al

Left main PCI: are we giving the kiss the attention it deserves?

Find the latest trials:

TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more

This Week's JAA's: CULPRIT-SHOCK substudy, Coronary Microcatheter Complications...

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke